Founded Year

2015

Stage

Series F | Alive

Total Raised

$448M

Last Raised

$165M | 10 mos ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

-15 points in the past 30 days

About LetsGetChecked

LetsGetChecked is a virtual care company that provides at-home health testing and telehealth services. The company offers a variety of health tests with online results, virtual consultations, and prescription medication delivery. LetsGetChecked serves individuals seeking healthcare solutions and organizations looking for employee wellness programs. It was founded in 2015 and is based in New York, New York.

Headquarters Location

330 West 38th Street Suite 405

New York, New York, 10018,

United States

315-508-7414

Loading...

LetsGetChecked's Product Videos

ESPs containing LetsGetChecked

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Care Delivery & Navigation Tech

The virtual & hybrid pediatric care market includes digital health platforms delivering medical and mental health services to children and families through telehealth technologies. These solutions provide remote access to pediatricians, child psychiatrists, and therapists via mobile apps, web platforms, and messaging systems. Core functionalities include virtual consultations for pediatric care, m…

LetsGetChecked named as Leader among 11 other companies, including Maven, Brightline, and Hazel.

LetsGetChecked's Products & Differentiators

    Home lab testing

    Providing easy-to-understand and actionable health insights for over1200 biomarkers from the comfort of home. Powered by our high-complexity labs around the world.

Loading...

Research containing LetsGetChecked

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned LetsGetChecked in 3 CB Insights research briefs, most recently on Oct 17, 2024.

Expert Collections containing LetsGetChecked

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

LetsGetChecked is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,309 items

D

Digital Health 50

450 items

The most promising digital health startups transforming the healthcare industry

D

Digital Health

12,122 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

T

Telehealth

3,123 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

W

Women's Health Tech

713 items

This collection includes companies applying technology to address a spectrum of physical, mental, and social well-being concerns specific to women. Examples include companies in reproductive health, maternal care, fertility tracking, and menopause support.

Latest LetsGetChecked News

At-Home Fertility Hormone Patch Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029

Nov 13, 2025

Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, November 12, 2025 / EINPresswire.com / -- What Is The Forecast For The At-Home Fertility Hormone Patch Market From 2025 To 2029? Recently, there has been a swift escalation in the market size of at-home fertility hormone patches. The projection for this market is to expand from $0.51 billion in 2024 to approximately $0.59 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. Several factors have contributed to the market's historical growth. These include increased awareness surrounding infertility and the trend of delayed child bearing, the rise of home-use diagnostic and monitoring tools, fertility clinic overcrowding leading to longer wait times, the emergence of direct-to-consumer telemedicine services, and an uptick in investment in femtech and women's health startups. Expectations are high for substantial expansion in the at-home fertility hormone patch market in the upcoming years. The market is projected to balloon to $1.05 billion by 2029 with a compound annual growth rate (CAGR) of 15.4%. Factors contributing to this growth during the forecast period include the widening of global distribution and direct-to-consumer networks, favorable adjustment to regulatory pathways and reimbursement enlargement, enhanced knowledge of reproductive health, increased adoption of home-based diagnostic methods, and a growing demand for non-invasive fertility tracking. Key trends forecasted for this period include innovation in wearable hormone monitoring, inclusion of telehealth for fertility advice, tailored fertility insights powered by analytics, product development centered on affordability, and significant strides forward in hormone patch technology. Download a free sample of the at-home fertility hormone patch market report: https://www.thebusinessresearchcompany.com/sample.aspx?id=28937&type=smp What Are The Core Growth Drivers Shaping The Future Of The At-Home Fertility Hormone Patch Market? The escalating rates of infertility are anticipated to fuel the development of the at-home fertility hormone patch market in the future. Infertility, a medical issue marked by the incapacity to become pregnant after a year of unprotected intercourse regularly, or physical troubles conceiving or delivering a live child, is becoming more prevalent. This increase is primarily due to the deferral of childbearing, as individuals are increasingly putting off starting a family until later in their reproductive years when aspects such as egg quality, ovarian reserve, and sperm parameters are significantly reducing the likelihood of conception. The growing infertility problem increases the necessity for at-home fertility hormone examination solutions, such as hormone patching, which allows for accessible and non-invasive monitoring of reproductive hormones. These tests aid in the detection of ovulation patterns, the identification of fertile windows, and the making of informed reproductive health decisions without frequent trips to the clinic. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported in April 2023 that approximately 17.5% of the adult population, or around 1 in 6 people worldwide, are infertile, showing the urgent necessity for affordable and superior fertility care. Hence, the rising prevalence of infertility is the primary driver of the at-home fertility hormone patch market's growth. Rising financial support for women's health initiatives is also powering the growth of the at-home fertility hormone patch market, as it addresses existing health disparities and the need for easily available community-based services. Women's health initiatives are endeavours, policies, or campaigns aimed at enhancing women's physical, mental, and reproductive health. These initiatives have been receiving more investment due to the ongoing acknowledgment of disparities in healthcare, whereby women's pain and health issues have often been dismissed or underestimated by the medical community, leading to disjointed services and poor health outcomes that necessitate structural changes. By funding research, enhancing accessibility, and addressing historical gaps in reproductive healthcare, investments into women's health initiatives enable technological advancements such as the at-home fertility hormone patch. It encourages women to keep track of and control their fertility from home safely and simply. For instance, the UK's Department of Health and Social Care reported in March 2025 that they allocated around $32 million (£25 million) between fiscal years 2023-2024 and 2024-2025 to local systems to set up women's health hubs as a conceptual demonstration. Thus, the ongoing investment into women's health initiatives is contributing to the growth of the at-home fertility hormone patch market. Which Companies Are Currently Leading In The At-Home Fertility Hormone Patch Market? Major players in the At-Home Fertility Hormone Patch Global Market Report 2025 include: • Amneal Pharmaceuticals LLC • LetsGetChecked Limited • Kindbody Inc. • Natural Cycles AB • Jolly Healthcare Pvt. Ltd. • TMRW Life Sciences Inc. • Easy-Healthcare-Corp • Tempdrop Inc. • YO Home Test Inc. • Hormona AB What Are The Key Trends And Market Opportunities In The At-Home Fertility Hormone Patch Sector? Leading firms in the at-home fertility hormone patch market are prioritizing the creation of cutting-edge solutions like deoxyribonucleic acid (DNA) infused wearable patches. These innovative devices utilize sensors derived from DNA to identify hormone levels in interstitial fluid, allowing people to track hormonal changes in real time, minus the discomfort of blood tests. It aids in monitoring fertility and general hormonal health. For instance, in February 2025, Level Zero Health Inc., a UK-based biotech company, secured $6.9 million during a popular pre-seed investment round. The funds will be used to create the inaugural continuous hormone monitoring patch worldwide. The firm's wearable patch, powered by DNA, tracks vital hormones like cortisol, progesterone, estrogen, and testosterone in the interstitial fluid, providing real-time information for fertility tracking, hormonal health management, and virtual clinic surveillance. This painless device lets users keep an eye on their hormone levels on an ongoing or sporadic basis using a handy patch worn on the arm. It reduces the necessity for hospital visits and uncomfortable procedures. Initially, the startup aims to cater to B2B clinical uses, such as fertility clinics and endocrine therapy centers, while also preparing for a likely venture into customer-based wellness markets. Comparative Analysis Of Leading At-Home Fertility Hormone Patch Market Segments The at-home fertility hormone patchmarket covered in this report is segmented – 1) By Product Type: Single-Use Patch, Reusable Patch 2) By Hormone Type: Estrogen, Progesterone, Luteinizing Hormone, Follicle-Stimulating Hormone, Other Hormone Types 3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Supermarkets Or Hypermarkets, Other Distribution Channels 4) By Application: Female Fertility Testing, Male Fertility Testing 5) By End-User: Home Care, Clinics, Hospitals, Other End Users Subsegments: 1) By Single-Use Patch: Disposable Fertility Hormone Patches, One-Time Ovulation Monitoring Patches, Single-Cycle Hormone Tracking Patches, Adhesive Single-Use Hormone Detection Patches 2) By Reusable Patch: Multi-Cycle Fertility Hormone Patches, Rechargeable Hormone Monitoring Patches, Long-Term Wearable Hormone Tracking Patches, Smart Reusable Hormone Patches View the full at-home fertility hormone patch market report: https://www.thebusinessresearchcompany.com/report/at-home-fertility-hormone-patch-global-market-report Which Regions Are Dominating The At-Home Fertility Hormone Patch Market Landscape? In the 2025 Global Market Report for At-Home Fertility Hormone Patch, North America led as the largest region in 2024 with expected growth. The report includes regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, Africa, in addition to North America. Browse Through More Reports Similar to the Global At-Home Fertility Hormone Patch Market 2025, By The Business Research Company Fertility Treatments Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report Fertility Drugs Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report Infertility Treatment Global Market Report Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report Speak With Our Expert: Saumya Sahay Americas +1 310-496-7795 Asia +44 7882 955267 & +91 8897263534 Europe +44 7882 955267 Email: saumyas@tbrc.info The Business Research Company - www.thebusinessresearchcompany.com Follow Us On: • LinkedIn: https://in.linkedin.com/company/the-business-research-company Oliver Guirdham The Business Research Company info@tbrc.info Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

LetsGetChecked Frequently Asked Questions (FAQ)

  • When was LetsGetChecked founded?

    LetsGetChecked was founded in 2015.

  • Where is LetsGetChecked's headquarters?

    LetsGetChecked's headquarters is located at 330 West 38th Street, New York.

  • What is LetsGetChecked's latest funding round?

    LetsGetChecked's latest funding round is Series F.

  • How much did LetsGetChecked raise?

    LetsGetChecked raised a total of $448M.

  • Who are the investors of LetsGetChecked?

    Investors of LetsGetChecked include Transformation Capital, Casdin Capital, Morgan Health, Qiming Venture Partners, Optum Ventures and 14 more.

  • Who are LetsGetChecked's competitors?

    Competitors of LetsGetChecked include Qured, 23andMe, Genalyte, Quest, imaware and 7 more.

  • What products does LetsGetChecked offer?

    LetsGetChecked's products include Home lab testing and 3 more.

Loading...

Compare LetsGetChecked to Competitors

Everlywell Logo
Everlywell

Everlywell operates as a digital health company providing at-home health testing and virtual healthcare services. The company offers various laboratory test kits that provide health insights based on biomarkers, including tests for food sensitivities, sexually transmitted infections (STIs), hormone levels, and thyroid function. It was founded in 2015 and is based in Austin, Texas.

Helix Logo
Helix

Helix focuses on integrating genomics into healthcare, medical research, diagnosis, treatment, and prevention within the health systems, public health, and life sciences sectors. The company provides access to genomic data for health systems, life sciences companies, and public health organizations. It was founded in 2015 and is based in San Mateo, California.

Thriva Logo
Thriva

Thriva operates as a healthcare platform that provides personalized health tests. It is a digital health business that provides tests to monitor and track a range of biomarkers, from gut health to heavy metals to hormones, to help people understand the state of their health. It offers finger-prick blood tests that can be done at home. The company was founded in 2016 and is based in London, United Kingdom.

Molecular You Logo
Molecular You

Molecular You provides preventive health assessments and lifestyle coaching within the health sector. The company offers a health report based on blood profile analysis, detailing an individual's current health status and future disease risks. It serves individuals seeking personalized health care and organizations interested in population health management. It was founded in 2014 and is based in Vancouver, Canada.

Swift Medical Logo
Swift Medical

Swift Medical focuses on digital wound care management in the healthcare sector. The company offers smartphone-ready software that provides advanced wound care visualization and touchless 3D measurement and streamlines both clinical and administrative wound care management workflows. The company primarily serves healthcare providers, payers, risk-bearing providers, and clinical research and trials. It was founded in 2015 and is based in Toronto, Canada.

Healthy.io Logo
Healthy.io

Healthy.io specializes in providing at-home kidney testing and digital wound care services that yield results accessible via smartphone. Its services aim to enhance patient experience and support early detection of health issues. It was founded in 2013 and is based in Tel Aviv, Israel.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.